Hemodynamic effects of intravenous timolol in coronary artery disease.
The hemodynamic effects of intravenous timolol were evaluated in 20 patients with coronary artery disease during diagnostic cardiac catheterization. The threshold dose of 0.25 mg reduced heart rate and cardiac index by 15% (p less than 0.05), left ventricular work index by 21% (p less than 0.05), and left ventricular dp/dt by 16% (p less than 0.05) while increasing left ventricular end-diastolic pressure by 49% (p less than 0.01), mean pulmonary arterial pressure by 17% (p less than 0.01), and systemic vascular resistance by 16% (NS). Larger doses (0.5 mg and 1.0 mg) induced similar responses with a greater effect on systemic vascular resistance (+22%, p less than 0.01, and +31%, p less than 0.001). The mean arterial pressure and stroke volumes were not affected by timolol. Peak effects, occurring at about 10 min after drug injection, did not correlate with plasma levels. The overall hemodynamic effects of timolol were similar to those reported for equipotent doses of propranolol and could be accounted for by the beta-adrenoceptor blocking activity.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003327:Coronary Disease / Q000503:physiopathology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000008:administration & dosage*; D011651:Pulmonary Artery / Q000503:physiopathology; D013999:Timolol / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D011412:Propanolamines; D013999:Timolol